LEADER 01850nam  2200361   450 
001 9910674395103321
005 20230625183401.0
035   $a(CKB)5400000000042913
035   $a(NjHacI)995400000000042913
035   $a(EXLCZ)995400000000042913
100   $a20230625d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPsychoneurobiology research and personalized treatment of schizophrenia /$fTomiki Sumiyoshi
210  1$aBasel :$cMDPI - Multidisciplinary Digital Publishing Institute,$d[2022]
215   $a1 online resource (133 pages)
311   $a3-0365-2859-8 
330   $aSchizophrenia is a common disease characterized by psychotic symptoms (e.g., delusion, hallucinations, blunted affect) and disturbances of cognitive function (e.g., memory, abstraction, attention). If not treated properly, patients may experience serious consequences in terms of social function. Much endeavor in several disciplines of medical science has been made to overcome the paucity of effective treatments for unmet needs, including cognitive impairment associated with schizophrenia.This Book, contributed by experts from various regions of the globe, provides up-to-date information to facilitate the development of personal therapeutics for this enigmatic illness.
606   $aSchizophrenia$xTreatment
606   $aSchizophrenia$xTreatment$xComplications
615  0$aSchizophrenia$xTreatment.
615  0$aSchizophrenia$xTreatment$xComplications.
676   $a616.8982
700   $aSumiyoshi$b Tomiki$01322353
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910674395103321
996   $aPsychoneurobiology research and personalized treatment of schizophrenia$93392839
997   $aUNINA